88 related articles for article (PubMed ID: 32417407)
21. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
[TBL] [Abstract][Full Text] [Related]
23. The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.
Mendoza Mireles EE; Skaga E; Server A; Leske H; Brandal P; Helseth E; Rønning PA; Vik-Mo EO
Neurooncol Pract; 2023 Dec; 10(6):555-564. PubMed ID: 38026582
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives.
Birzu C; French P; Caccese M; Cerretti G; Idbaih A; Zagonel V; Lombardi G
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375286
[TBL] [Abstract][Full Text] [Related]
25. Alkylating agents are possible inducers of glioblastoma and other brain tumors.
Smith CJ; Perfetti TA; Chokshi C; Venugopal C; Ashford JW; Singh SK
Hum Exp Toxicol; 2024; 43():9603271241256598. PubMed ID: 38758727
[TBL] [Abstract][Full Text] [Related]
26. Germline polymorphisms in
Scheurer ME; Zhou R; Gilbert MR; Bondy ML; Sulman EP; Yuan Y; Liu Y; Vera E; Wendland MM; Youssef EF; Stieber VW; Komaki RR; Flickinger JC; Kenyon LC; Robins HI; Hunter GK; Crocker IR; Chao ST; Pugh SL; Armstrong TS
Neurooncol Adv; 2022; 4(1):vdac152. PubMed ID: 36299794
[TBL] [Abstract][Full Text] [Related]
27. Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes.
Christenson C; Wu C; Hormuth DA; Huang S; Bao A; Brenner A; Yankeelov TE
Brain Multiphys; 2023 Dec; 5():. PubMed ID: 38187909
[TBL] [Abstract][Full Text] [Related]
28. Individualized survival prediction and surgery recommendation for patients with glioblastoma.
Zhu E; Wang J; Jing Q; Shi W; Xu Z; Ai P; Chen Z; Dai Z; Shan D; Ai Z
Front Med (Lausanne); 2024; 11():1330907. PubMed ID: 38784239
[TBL] [Abstract][Full Text] [Related]
29. Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.
Pham LC; Weller L; Gann CN; Schumacher KM; Vlassak S; Swanson T; Highsmith K; O'Brien BJ; Nash S; Aaroe A; de Groot JF; Majd NK
Oncologist; 2024 May; ():. PubMed ID: 38815166
[TBL] [Abstract][Full Text] [Related]
30. Emerging Therapies for Glioblastoma.
Rios SA; Oyervides S; Uribe D; Reyes AM; Fanniel V; Vazquez J; Keniry M
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672566
[TBL] [Abstract][Full Text] [Related]
31. A living ex vivo platform for functional, personalized brain cancer diagnosis.
Mann B; Zhang X; Bell N; Adefolaju A; Thang M; Dasari R; Kanchi K; Valdivia A; Yang Y; Buckley A; Lettry V; Quinsey C; Rauf Y; Kram D; Cassidy N; Vaziri C; Corcoran DL; Rego S; Jiang Y; Graves LM; Dunn D; Floyd S; Baldwin A; Hingtgen S; Satterlee AB
Cell Rep Med; 2023 Jun; 4(6):101042. PubMed ID: 37192626
[TBL] [Abstract][Full Text] [Related]
32. Personalized single-cell networks: a framework to predict the response of any gene to any drug for any patient.
Harikumar H; Quinn TP; Rana S; Gupta S; Venkatesh S
BioData Min; 2021 Aug; 14(1):37. PubMed ID: 34353329
[TBL] [Abstract][Full Text] [Related]
33. Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma.
Iorgulescu JB; Gokhale PC; Speranza MC; Eschle BK; Poitras MJ; Wilkens MK; Soroko KM; Chhoeu C; Knott A; Gao Y; Lim-Fat MJ; Baker GJ; Bonal DM; Nguyen QD; Grant GRL; Ligon KL; Sorger PK; Chiocca EA; Anderson AC; Kirschmeier PT; Sharpe AH; Freeman GJ; Reardon DA
Clin Cancer Res; 2021 Jan; 27(1):276-287. PubMed ID: 33239433
[TBL] [Abstract][Full Text] [Related]
34. The Temozolomide-Doxorubicin paradox in Glioblastoma in vitro-in silico preclinical drug-screening.
Oraiopoulou ME; Tzamali E; Psycharakis SE; Tzedakis G; Makatounakis T; Manolitsi K; Drakos E; Vakis AF; Zacharakis G; Papamatheakis J; Sakkalis V
Sci Rep; 2024 Feb; 14(1):3759. PubMed ID: 38355655
[TBL] [Abstract][Full Text] [Related]
35. Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers.
Rabah N; Ait Mohand FE; Kravchenko-Balasha N
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762559
[TBL] [Abstract][Full Text] [Related]
36. Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Rahman R; Polley MC; Alder L; Brastianos PK; Anders CK; Tawbi HA; Mehta M; Wen PY; Geyer S; de Groot J; Zadeh G; Piantadosi S; Galanis E; Khasraw M
Lancet Oncol; 2023 Apr; 24(4):e161-e171. PubMed ID: 36990614
[TBL] [Abstract][Full Text] [Related]
37. Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report.
Castro MP; Khanlou N; Fallah A; Pampana A; Alam A; Lala DA; Roy KGG; Amara ARR; Prakash A; Singh D; Behura L; Kumar A; Kapoor S
Ann Transl Med; 2022 Dec; 10(23):1289. PubMed ID: 36618786
[TBL] [Abstract][Full Text] [Related]
38. The current state of glioma data registries.
Yearley AG; Iorgulescu JB; Chiocca EA; Peruzzi PP; Smith TR; Reardon DA; Mooney MA
Neurooncol Adv; 2022; 4(1):vdac099. PubMed ID: 36196363
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.
Castro M; Pampana A; Alam A; Parashar R; Rajagopalan S; Lala DA; Roy KGG; Basu S; Prakash A; Nair P; Joseph V; Agarwal A; G P; Behura L; Kulkarni S; Choudhary NR; Kapoor S
J Neurooncol; 2021 Jul; 153(3):393-402. PubMed ID: 34101093
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.
Rahman R; Trippa L; Alden S; Fell G; Abbasi T; Mundkur Y; Singh NK; Talawdekar A; Husain Z; Vali S; Ligon KL; Wen PY; Alexander BM
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):716-724. PubMed ID: 32417407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
